第十一届癌症免疫疗法会议 (ITOC):会议报告
Stefanos Michaelides1, Viktoria Hartmann1, Volkmar Nüssler2
1Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.
Human vaccines & immunotherapeutics
|July 18, 2025
概括
第11届癌症免疫疗法 (ITOC) 会议强调了免疫瘤学的进步,展示了从基础概念到癌症免疫学的前沿发现的研究. 讨论强调了瘤免疫学的广泛范围,不仅仅是癌症和免疫细胞.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 癌症免疫疗法 (ITOC) 是一年一度的国际会议.
- 第11届 (ITOC11) 将于2025年4月在慕尼黑召开.
- 该会议是免疫瘤学家分享研究和讨论新发现的全球平台.
研究的目的:
- 介绍和讨论免疫瘤学的最新研究和发现.
- 探索该领域的新概念和临床结果.
- 反思癌症免疫学的历史发展和未来方向.
主要方法:
- 全球免疫瘤学家的研究报告.
- 讨论新的概念和临床结果.
- 奖项是对该领域的重大贡献的认可 (例如,终身成就奖).
主要成果:
- ITOC11在免疫瘤学方面取得了重大进展.
- 讨论涵盖了从历史基础到当前进展的范围.
- 会议强调了瘤免疫学的扩展性.
结论:
- 免疫瘤学已经大大发展,将历史见解与新发现相结合.
- 瘤免疫学领域不仅包括癌症和免疫细胞.
- ITOC11强调了癌症免疫疗法研究的动态和不断扩大的景观.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.1K
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
